nodes	percent_of_prediction	percent_of_DWPC	metapath
Metronidazole—CYP3A4—bone cancer	0.794	1	CbGaD
Metronidazole—Tinidazole—CYP3A4—bone cancer	0.00881	1	CrCbGaD
Metronidazole—Pancytopenia—Epirubicin—bone cancer	0.000294	0.00149	CcSEcCtD
Metronidazole—Pain—Cisplatin—bone cancer	0.000293	0.00148	CcSEcCtD
Metronidazole—Stevens-Johnson syndrome—Methotrexate—bone cancer	0.000292	0.00148	CcSEcCtD
Metronidazole—Dysuria—Epirubicin—bone cancer	0.000289	0.00146	CcSEcCtD
Metronidazole—Neutropenia—Epirubicin—bone cancer	0.000289	0.00146	CcSEcCtD
Metronidazole—Abdominal distension—Doxorubicin—bone cancer	0.000288	0.00146	CcSEcCtD
Metronidazole—Upper respiratory tract infection—Epirubicin—bone cancer	0.000287	0.00146	CcSEcCtD
Metronidazole—Stomatitis—Methotrexate—bone cancer	0.000287	0.00145	CcSEcCtD
Metronidazole—Conjunctivitis—Methotrexate—bone cancer	0.000286	0.00145	CcSEcCtD
Metronidazole—Asthma—Doxorubicin—bone cancer	0.000286	0.00145	CcSEcCtD
Metronidazole—Influenza—Doxorubicin—bone cancer	0.000286	0.00145	CcSEcCtD
Metronidazole—Pollakiuria—Epirubicin—bone cancer	0.000286	0.00145	CcSEcCtD
Metronidazole—Eosinophilia—Doxorubicin—bone cancer	0.000283	0.00143	CcSEcCtD
Metronidazole—Sweating—Methotrexate—bone cancer	0.000282	0.00143	CcSEcCtD
Metronidazole—Photosensitivity reaction—Epirubicin—bone cancer	0.000282	0.00143	CcSEcCtD
Metronidazole—Feeling abnormal—Cisplatin—bone cancer	0.000282	0.00143	CcSEcCtD
Metronidazole—Pancreatitis—Doxorubicin—bone cancer	0.00028	0.00142	CcSEcCtD
Metronidazole—Hepatobiliary disease—Methotrexate—bone cancer	0.000279	0.00141	CcSEcCtD
Metronidazole—Drowsiness—Epirubicin—bone cancer	0.000276	0.0014	CcSEcCtD
Metronidazole—Infestation NOS—Epirubicin—bone cancer	0.000276	0.0014	CcSEcCtD
Metronidazole—Infestation—Epirubicin—bone cancer	0.000276	0.0014	CcSEcCtD
Metronidazole—Bronchitis—Doxorubicin—bone cancer	0.000275	0.00139	CcSEcCtD
Metronidazole—Agranulocytosis—Methotrexate—bone cancer	0.000275	0.00139	CcSEcCtD
Metronidazole—Stevens-Johnson syndrome—Epirubicin—bone cancer	0.000273	0.00138	CcSEcCtD
Metronidazole—Pancytopenia—Doxorubicin—bone cancer	0.000272	0.00138	CcSEcCtD
Metronidazole—Body temperature increased—Cisplatin—bone cancer	0.000271	0.00137	CcSEcCtD
Metronidazole—Neuropathy peripheral—Epirubicin—bone cancer	0.00027	0.00137	CcSEcCtD
Metronidazole—Jaundice—Epirubicin—bone cancer	0.000269	0.00136	CcSEcCtD
Metronidazole—Stomatitis—Epirubicin—bone cancer	0.000269	0.00136	CcSEcCtD
Metronidazole—Urinary tract infection—Epirubicin—bone cancer	0.000268	0.00136	CcSEcCtD
Metronidazole—Conjunctivitis—Epirubicin—bone cancer	0.000268	0.00136	CcSEcCtD
Metronidazole—Neutropenia—Doxorubicin—bone cancer	0.000267	0.00135	CcSEcCtD
Metronidazole—Dysuria—Doxorubicin—bone cancer	0.000267	0.00135	CcSEcCtD
Metronidazole—Upper respiratory tract infection—Doxorubicin—bone cancer	0.000266	0.00135	CcSEcCtD
Metronidazole—Hepatitis—Methotrexate—bone cancer	0.000264	0.00134	CcSEcCtD
Metronidazole—Sweating—Epirubicin—bone cancer	0.000264	0.00134	CcSEcCtD
Metronidazole—Pollakiuria—Doxorubicin—bone cancer	0.000264	0.00134	CcSEcCtD
Metronidazole—Pharyngitis—Methotrexate—bone cancer	0.000262	0.00133	CcSEcCtD
Metronidazole—Photosensitivity reaction—Doxorubicin—bone cancer	0.000261	0.00132	CcSEcCtD
Metronidazole—Hepatobiliary disease—Epirubicin—bone cancer	0.000261	0.00132	CcSEcCtD
Metronidazole—Sinusitis—Epirubicin—bone cancer	0.000259	0.00131	CcSEcCtD
Metronidazole—Agranulocytosis—Epirubicin—bone cancer	0.000257	0.0013	CcSEcCtD
Metronidazole—Infestation—Doxorubicin—bone cancer	0.000255	0.00129	CcSEcCtD
Metronidazole—Infestation NOS—Doxorubicin—bone cancer	0.000255	0.00129	CcSEcCtD
Metronidazole—Drowsiness—Doxorubicin—bone cancer	0.000255	0.00129	CcSEcCtD
Metronidazole—Visual impairment—Methotrexate—bone cancer	0.000255	0.00129	CcSEcCtD
Metronidazole—Stevens-Johnson syndrome—Doxorubicin—bone cancer	0.000253	0.00128	CcSEcCtD
Metronidazole—Hypersensitivity—Cisplatin—bone cancer	0.000252	0.00128	CcSEcCtD
Metronidazole—Erythema multiforme—Methotrexate—bone cancer	0.00025	0.00127	CcSEcCtD
Metronidazole—Neuropathy peripheral—Doxorubicin—bone cancer	0.00025	0.00127	CcSEcCtD
Metronidazole—Stomatitis—Doxorubicin—bone cancer	0.000249	0.00126	CcSEcCtD
Metronidazole—Jaundice—Doxorubicin—bone cancer	0.000249	0.00126	CcSEcCtD
Metronidazole—Rhinitis—Epirubicin—bone cancer	0.000248	0.00126	CcSEcCtD
Metronidazole—Urinary tract infection—Doxorubicin—bone cancer	0.000248	0.00126	CcSEcCtD
Metronidazole—Conjunctivitis—Doxorubicin—bone cancer	0.000248	0.00126	CcSEcCtD
Metronidazole—Hepatitis—Epirubicin—bone cancer	0.000247	0.00125	CcSEcCtD
Metronidazole—Eye disorder—Methotrexate—bone cancer	0.000247	0.00125	CcSEcCtD
Metronidazole—Tinnitus—Methotrexate—bone cancer	0.000247	0.00125	CcSEcCtD
Metronidazole—Hypoaesthesia—Epirubicin—bone cancer	0.000246	0.00125	CcSEcCtD
Metronidazole—Asthenia—Cisplatin—bone cancer	0.000246	0.00124	CcSEcCtD
Metronidazole—Pharyngitis—Epirubicin—bone cancer	0.000246	0.00124	CcSEcCtD
Metronidazole—Cardiac disorder—Methotrexate—bone cancer	0.000245	0.00124	CcSEcCtD
Metronidazole—Sweating—Doxorubicin—bone cancer	0.000245	0.00124	CcSEcCtD
Metronidazole—Connective tissue disorder—Epirubicin—bone cancer	0.000243	0.00123	CcSEcCtD
Metronidazole—Hepatobiliary disease—Doxorubicin—bone cancer	0.000241	0.00122	CcSEcCtD
Metronidazole—Angiopathy—Methotrexate—bone cancer	0.00024	0.00122	CcSEcCtD
Metronidazole—Sinusitis—Doxorubicin—bone cancer	0.000239	0.00121	CcSEcCtD
Metronidazole—Immune system disorder—Methotrexate—bone cancer	0.000239	0.00121	CcSEcCtD
Metronidazole—Visual impairment—Epirubicin—bone cancer	0.000238	0.00121	CcSEcCtD
Metronidazole—Mediastinal disorder—Methotrexate—bone cancer	0.000238	0.00121	CcSEcCtD
Metronidazole—Agranulocytosis—Doxorubicin—bone cancer	0.000238	0.00121	CcSEcCtD
Metronidazole—Diarrhoea—Cisplatin—bone cancer	0.000234	0.00119	CcSEcCtD
Metronidazole—Erythema multiforme—Epirubicin—bone cancer	0.000234	0.00118	CcSEcCtD
Metronidazole—Mental disorder—Methotrexate—bone cancer	0.000232	0.00117	CcSEcCtD
Metronidazole—Eye disorder—Epirubicin—bone cancer	0.000231	0.00117	CcSEcCtD
Metronidazole—Tinnitus—Epirubicin—bone cancer	0.000231	0.00117	CcSEcCtD
Metronidazole—Erythema—Methotrexate—bone cancer	0.00023	0.00117	CcSEcCtD
Metronidazole—Flushing—Epirubicin—bone cancer	0.00023	0.00116	CcSEcCtD
Metronidazole—Cardiac disorder—Epirubicin—bone cancer	0.00023	0.00116	CcSEcCtD
Metronidazole—Rhinitis—Doxorubicin—bone cancer	0.00023	0.00116	CcSEcCtD
Metronidazole—Hepatitis—Doxorubicin—bone cancer	0.000229	0.00116	CcSEcCtD
Metronidazole—Hypoaesthesia—Doxorubicin—bone cancer	0.000228	0.00115	CcSEcCtD
Metronidazole—Pharyngitis—Doxorubicin—bone cancer	0.000227	0.00115	CcSEcCtD
Metronidazole—Dysgeusia—Methotrexate—bone cancer	0.000225	0.00114	CcSEcCtD
Metronidazole—Connective tissue disorder—Doxorubicin—bone cancer	0.000225	0.00114	CcSEcCtD
Metronidazole—Angiopathy—Epirubicin—bone cancer	0.000225	0.00114	CcSEcCtD
Metronidazole—Immune system disorder—Epirubicin—bone cancer	0.000224	0.00113	CcSEcCtD
Metronidazole—Mediastinal disorder—Epirubicin—bone cancer	0.000223	0.00113	CcSEcCtD
Metronidazole—Back pain—Methotrexate—bone cancer	0.000223	0.00113	CcSEcCtD
Metronidazole—Visual impairment—Doxorubicin—bone cancer	0.000221	0.00112	CcSEcCtD
Metronidazole—Vomiting—Cisplatin—bone cancer	0.000218	0.0011	CcSEcCtD
Metronidazole—Vision blurred—Methotrexate—bone cancer	0.000217	0.0011	CcSEcCtD
Metronidazole—Mental disorder—Epirubicin—bone cancer	0.000217	0.0011	CcSEcCtD
Metronidazole—Erythema multiforme—Doxorubicin—bone cancer	0.000216	0.0011	CcSEcCtD
Metronidazole—Rash—Cisplatin—bone cancer	0.000216	0.00109	CcSEcCtD
Metronidazole—Dermatitis—Cisplatin—bone cancer	0.000216	0.00109	CcSEcCtD
Metronidazole—Erythema—Epirubicin—bone cancer	0.000215	0.00109	CcSEcCtD
Metronidazole—Eye disorder—Doxorubicin—bone cancer	0.000214	0.00108	CcSEcCtD
Metronidazole—Tinnitus—Doxorubicin—bone cancer	0.000213	0.00108	CcSEcCtD
Metronidazole—Cardiac disorder—Doxorubicin—bone cancer	0.000212	0.00108	CcSEcCtD
Metronidazole—Flushing—Doxorubicin—bone cancer	0.000212	0.00108	CcSEcCtD
Metronidazole—Flatulence—Epirubicin—bone cancer	0.000212	0.00108	CcSEcCtD
Metronidazole—Dysgeusia—Epirubicin—bone cancer	0.000211	0.00107	CcSEcCtD
Metronidazole—Back pain—Epirubicin—bone cancer	0.000208	0.00106	CcSEcCtD
Metronidazole—Angiopathy—Doxorubicin—bone cancer	0.000208	0.00105	CcSEcCtD
Metronidazole—Malaise—Methotrexate—bone cancer	0.000208	0.00105	CcSEcCtD
Metronidazole—Muscle spasms—Epirubicin—bone cancer	0.000207	0.00105	CcSEcCtD
Metronidazole—Immune system disorder—Doxorubicin—bone cancer	0.000207	0.00105	CcSEcCtD
Metronidazole—Vertigo—Methotrexate—bone cancer	0.000207	0.00105	CcSEcCtD
Metronidazole—Mediastinal disorder—Doxorubicin—bone cancer	0.000206	0.00105	CcSEcCtD
Metronidazole—Leukopenia—Methotrexate—bone cancer	0.000206	0.00104	CcSEcCtD
Metronidazole—Nausea—Cisplatin—bone cancer	0.000203	0.00103	CcSEcCtD
Metronidazole—Vision blurred—Epirubicin—bone cancer	0.000203	0.00103	CcSEcCtD
Metronidazole—Mental disorder—Doxorubicin—bone cancer	0.000201	0.00102	CcSEcCtD
Metronidazole—Convulsion—Methotrexate—bone cancer	0.000199	0.00101	CcSEcCtD
Metronidazole—Erythema—Doxorubicin—bone cancer	0.000199	0.00101	CcSEcCtD
Metronidazole—Flatulence—Doxorubicin—bone cancer	0.000196	0.000995	CcSEcCtD
Metronidazole—Chest pain—Methotrexate—bone cancer	0.000196	0.000992	CcSEcCtD
Metronidazole—Arthralgia—Methotrexate—bone cancer	0.000196	0.000992	CcSEcCtD
Metronidazole—Dysgeusia—Doxorubicin—bone cancer	0.000195	0.000989	CcSEcCtD
Metronidazole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.000195	0.000986	CcSEcCtD
Metronidazole—Malaise—Epirubicin—bone cancer	0.000194	0.000984	CcSEcCtD
Metronidazole—Vertigo—Epirubicin—bone cancer	0.000194	0.00098	CcSEcCtD
Metronidazole—Syncope—Epirubicin—bone cancer	0.000193	0.000978	CcSEcCtD
Metronidazole—Leukopenia—Epirubicin—bone cancer	0.000193	0.000977	CcSEcCtD
Metronidazole—Back pain—Doxorubicin—bone cancer	0.000193	0.000976	CcSEcCtD
Metronidazole—Muscle spasms—Doxorubicin—bone cancer	0.000192	0.000971	CcSEcCtD
Metronidazole—Palpitations—Epirubicin—bone cancer	0.00019	0.000964	CcSEcCtD
Metronidazole—Confusional state—Methotrexate—bone cancer	0.000189	0.000959	CcSEcCtD
Metronidazole—Loss of consciousness—Epirubicin—bone cancer	0.000189	0.000959	CcSEcCtD
Metronidazole—Anaphylactic shock—Methotrexate—bone cancer	0.000188	0.000951	CcSEcCtD
Metronidazole—Vision blurred—Doxorubicin—bone cancer	0.000188	0.000951	CcSEcCtD
Metronidazole—Convulsion—Epirubicin—bone cancer	0.000187	0.000945	CcSEcCtD
Metronidazole—Infection—Methotrexate—bone cancer	0.000187	0.000945	CcSEcCtD
Metronidazole—Hypertension—Epirubicin—bone cancer	0.000186	0.000942	CcSEcCtD
Metronidazole—Nervous system disorder—Methotrexate—bone cancer	0.000184	0.000933	CcSEcCtD
Metronidazole—Thrombocytopenia—Methotrexate—bone cancer	0.000184	0.000932	CcSEcCtD
Metronidazole—Chest pain—Epirubicin—bone cancer	0.000183	0.000929	CcSEcCtD
Metronidazole—Arthralgia—Epirubicin—bone cancer	0.000183	0.000929	CcSEcCtD
Metronidazole—Skin disorder—Methotrexate—bone cancer	0.000182	0.000924	CcSEcCtD
Metronidazole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.000182	0.000922	CcSEcCtD
Metronidazole—Hyperhidrosis—Methotrexate—bone cancer	0.000182	0.00092	CcSEcCtD
Metronidazole—Malaise—Doxorubicin—bone cancer	0.00018	0.00091	CcSEcCtD
Metronidazole—Dry mouth—Epirubicin—bone cancer	0.000179	0.000908	CcSEcCtD
Metronidazole—Vertigo—Doxorubicin—bone cancer	0.000179	0.000907	CcSEcCtD
Metronidazole—Anorexia—Methotrexate—bone cancer	0.000179	0.000907	CcSEcCtD
Metronidazole—Syncope—Doxorubicin—bone cancer	0.000179	0.000905	CcSEcCtD
Metronidazole—Leukopenia—Doxorubicin—bone cancer	0.000178	0.000904	CcSEcCtD
Metronidazole—Confusional state—Epirubicin—bone cancer	0.000177	0.000898	CcSEcCtD
Metronidazole—Palpitations—Doxorubicin—bone cancer	0.000176	0.000892	CcSEcCtD
Metronidazole—Anaphylactic shock—Epirubicin—bone cancer	0.000176	0.00089	CcSEcCtD
Metronidazole—Oedema—Epirubicin—bone cancer	0.000176	0.00089	CcSEcCtD
Metronidazole—Loss of consciousness—Doxorubicin—bone cancer	0.000175	0.000887	CcSEcCtD
Metronidazole—Infection—Epirubicin—bone cancer	0.000175	0.000885	CcSEcCtD
Metronidazole—Shock—Epirubicin—bone cancer	0.000173	0.000876	CcSEcCtD
Metronidazole—Convulsion—Doxorubicin—bone cancer	0.000173	0.000875	CcSEcCtD
Metronidazole—Nervous system disorder—Epirubicin—bone cancer	0.000172	0.000873	CcSEcCtD
Metronidazole—Thrombocytopenia—Epirubicin—bone cancer	0.000172	0.000872	CcSEcCtD
Metronidazole—Hypertension—Doxorubicin—bone cancer	0.000172	0.000872	CcSEcCtD
Metronidazole—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000171	0.000867	CcSEcCtD
Metronidazole—Skin disorder—Epirubicin—bone cancer	0.000171	0.000865	CcSEcCtD
Metronidazole—Hyperhidrosis—Epirubicin—bone cancer	0.00017	0.000861	CcSEcCtD
Metronidazole—Insomnia—Methotrexate—bone cancer	0.00017	0.000861	CcSEcCtD
Metronidazole—Chest pain—Doxorubicin—bone cancer	0.00017	0.000859	CcSEcCtD
Metronidazole—Arthralgia—Doxorubicin—bone cancer	0.00017	0.000859	CcSEcCtD
Metronidazole—Paraesthesia—Methotrexate—bone cancer	0.000169	0.000854	CcSEcCtD
Metronidazole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.000169	0.000853	CcSEcCtD
Metronidazole—Anorexia—Epirubicin—bone cancer	0.000168	0.000849	CcSEcCtD
Metronidazole—Somnolence—Methotrexate—bone cancer	0.000167	0.000846	CcSEcCtD
Metronidazole—Dry mouth—Doxorubicin—bone cancer	0.000166	0.00084	CcSEcCtD
Metronidazole—Dyspepsia—Methotrexate—bone cancer	0.000165	0.000837	CcSEcCtD
Metronidazole—Confusional state—Doxorubicin—bone cancer	0.000164	0.000831	CcSEcCtD
Metronidazole—Decreased appetite—Methotrexate—bone cancer	0.000163	0.000827	CcSEcCtD
Metronidazole—Oedema—Doxorubicin—bone cancer	0.000163	0.000824	CcSEcCtD
Metronidazole—Anaphylactic shock—Doxorubicin—bone cancer	0.000163	0.000824	CcSEcCtD
Metronidazole—Gastrointestinal disorder—Methotrexate—bone cancer	0.000162	0.000821	CcSEcCtD
Metronidazole—Fatigue—Methotrexate—bone cancer	0.000162	0.00082	CcSEcCtD
Metronidazole—Infection—Doxorubicin—bone cancer	0.000162	0.000818	CcSEcCtD
Metronidazole—Pain—Methotrexate—bone cancer	0.000161	0.000814	CcSEcCtD
Metronidazole—Musculoskeletal discomfort—Epirubicin—bone cancer	0.00016	0.000811	CcSEcCtD
Metronidazole—Shock—Doxorubicin—bone cancer	0.00016	0.000811	CcSEcCtD
Metronidazole—Nervous system disorder—Doxorubicin—bone cancer	0.00016	0.000808	CcSEcCtD
Metronidazole—Thrombocytopenia—Doxorubicin—bone cancer	0.000159	0.000807	CcSEcCtD
Metronidazole—Insomnia—Epirubicin—bone cancer	0.000159	0.000805	CcSEcCtD
Metronidazole—Skin disorder—Doxorubicin—bone cancer	0.000158	0.0008	CcSEcCtD
Metronidazole—Paraesthesia—Epirubicin—bone cancer	0.000158	0.0008	CcSEcCtD
Metronidazole—Hyperhidrosis—Doxorubicin—bone cancer	0.000157	0.000796	CcSEcCtD
Metronidazole—Somnolence—Epirubicin—bone cancer	0.000156	0.000792	CcSEcCtD
Metronidazole—Anorexia—Doxorubicin—bone cancer	0.000155	0.000785	CcSEcCtD
Metronidazole—Feeling abnormal—Methotrexate—bone cancer	0.000155	0.000784	CcSEcCtD
Metronidazole—Dyspepsia—Epirubicin—bone cancer	0.000155	0.000784	CcSEcCtD
Metronidazole—Gastrointestinal pain—Methotrexate—bone cancer	0.000154	0.000778	CcSEcCtD
Metronidazole—Decreased appetite—Epirubicin—bone cancer	0.000153	0.000774	CcSEcCtD
Metronidazole—Gastrointestinal disorder—Epirubicin—bone cancer	0.000152	0.000769	CcSEcCtD
Metronidazole—Fatigue—Epirubicin—bone cancer	0.000152	0.000768	CcSEcCtD
Metronidazole—Pain—Epirubicin—bone cancer	0.00015	0.000761	CcSEcCtD
Metronidazole—Constipation—Epirubicin—bone cancer	0.00015	0.000761	CcSEcCtD
Metronidazole—Urticaria—Methotrexate—bone cancer	0.000149	0.000756	CcSEcCtD
Metronidazole—Body temperature increased—Methotrexate—bone cancer	0.000149	0.000752	CcSEcCtD
Metronidazole—Abdominal pain—Methotrexate—bone cancer	0.000149	0.000752	CcSEcCtD
Metronidazole—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000148	0.000751	CcSEcCtD
Metronidazole—Insomnia—Doxorubicin—bone cancer	0.000147	0.000745	CcSEcCtD
Metronidazole—Paraesthesia—Doxorubicin—bone cancer	0.000146	0.00074	CcSEcCtD
Metronidazole—Feeling abnormal—Epirubicin—bone cancer	0.000145	0.000734	CcSEcCtD
Metronidazole—Somnolence—Doxorubicin—bone cancer	0.000145	0.000732	CcSEcCtD
Metronidazole—Gastrointestinal pain—Epirubicin—bone cancer	0.000144	0.000728	CcSEcCtD
Metronidazole—Dyspepsia—Doxorubicin—bone cancer	0.000143	0.000725	CcSEcCtD
Metronidazole—Decreased appetite—Doxorubicin—bone cancer	0.000141	0.000716	CcSEcCtD
Metronidazole—Gastrointestinal disorder—Doxorubicin—bone cancer	0.00014	0.000711	CcSEcCtD
Metronidazole—Fatigue—Doxorubicin—bone cancer	0.00014	0.00071	CcSEcCtD
Metronidazole—Urticaria—Epirubicin—bone cancer	0.00014	0.000707	CcSEcCtD
Metronidazole—Pain—Doxorubicin—bone cancer	0.000139	0.000705	CcSEcCtD
Metronidazole—Constipation—Doxorubicin—bone cancer	0.000139	0.000705	CcSEcCtD
Metronidazole—Body temperature increased—Epirubicin—bone cancer	0.000139	0.000704	CcSEcCtD
Metronidazole—Abdominal pain—Epirubicin—bone cancer	0.000139	0.000704	CcSEcCtD
Metronidazole—Hypersensitivity—Methotrexate—bone cancer	0.000138	0.000701	CcSEcCtD
Metronidazole—Asthenia—Methotrexate—bone cancer	0.000135	0.000683	CcSEcCtD
Metronidazole—Feeling abnormal—Doxorubicin—bone cancer	0.000134	0.000679	CcSEcCtD
Metronidazole—Gastrointestinal pain—Doxorubicin—bone cancer	0.000133	0.000674	CcSEcCtD
Metronidazole—Pruritus—Methotrexate—bone cancer	0.000133	0.000673	CcSEcCtD
Metronidazole—Hypersensitivity—Epirubicin—bone cancer	0.00013	0.000656	CcSEcCtD
Metronidazole—Urticaria—Doxorubicin—bone cancer	0.000129	0.000654	CcSEcCtD
Metronidazole—Abdominal pain—Doxorubicin—bone cancer	0.000129	0.000651	CcSEcCtD
Metronidazole—Body temperature increased—Doxorubicin—bone cancer	0.000129	0.000651	CcSEcCtD
Metronidazole—Diarrhoea—Methotrexate—bone cancer	0.000129	0.000651	CcSEcCtD
Metronidazole—Asthenia—Epirubicin—bone cancer	0.000126	0.000639	CcSEcCtD
Metronidazole—Pruritus—Epirubicin—bone cancer	0.000124	0.00063	CcSEcCtD
Metronidazole—Dizziness—Methotrexate—bone cancer	0.000124	0.000629	CcSEcCtD
Metronidazole—Diarrhoea—Epirubicin—bone cancer	0.00012	0.000609	CcSEcCtD
Metronidazole—Hypersensitivity—Doxorubicin—bone cancer	0.00012	0.000607	CcSEcCtD
Metronidazole—Vomiting—Methotrexate—bone cancer	0.000119	0.000605	CcSEcCtD
Metronidazole—Rash—Methotrexate—bone cancer	0.000118	0.0006	CcSEcCtD
Metronidazole—Dermatitis—Methotrexate—bone cancer	0.000118	0.000599	CcSEcCtD
Metronidazole—Headache—Methotrexate—bone cancer	0.000118	0.000596	CcSEcCtD
Metronidazole—Asthenia—Doxorubicin—bone cancer	0.000117	0.000591	CcSEcCtD
Metronidazole—Dizziness—Epirubicin—bone cancer	0.000116	0.000589	CcSEcCtD
Metronidazole—Pruritus—Doxorubicin—bone cancer	0.000115	0.000583	CcSEcCtD
Metronidazole—Vomiting—Epirubicin—bone cancer	0.000112	0.000566	CcSEcCtD
Metronidazole—Nausea—Methotrexate—bone cancer	0.000112	0.000565	CcSEcCtD
Metronidazole—Diarrhoea—Doxorubicin—bone cancer	0.000111	0.000564	CcSEcCtD
Metronidazole—Rash—Epirubicin—bone cancer	0.000111	0.000561	CcSEcCtD
Metronidazole—Dermatitis—Epirubicin—bone cancer	0.000111	0.000561	CcSEcCtD
Metronidazole—Headache—Epirubicin—bone cancer	0.00011	0.000558	CcSEcCtD
Metronidazole—Dizziness—Doxorubicin—bone cancer	0.000108	0.000545	CcSEcCtD
Metronidazole—Nausea—Epirubicin—bone cancer	0.000104	0.000529	CcSEcCtD
Metronidazole—Vomiting—Doxorubicin—bone cancer	0.000103	0.000524	CcSEcCtD
Metronidazole—Rash—Doxorubicin—bone cancer	0.000103	0.000519	CcSEcCtD
Metronidazole—Dermatitis—Doxorubicin—bone cancer	0.000102	0.000519	CcSEcCtD
Metronidazole—Headache—Doxorubicin—bone cancer	0.000102	0.000516	CcSEcCtD
Metronidazole—Nausea—Doxorubicin—bone cancer	9.66e-05	0.000489	CcSEcCtD
